Delta Leaf Labs is like Ancestry.com of Cannabis - except, better. We have a combined SaaS + web3/DAO strategy that completely upends the traditional model of data monetization in the genomic testing industry. We conduct laboratory & computational research to develop products and services without ever handling any plant material ourselves. I designed nucleic acid (DNA/RNA) collection kits that we ship to customers - who can then mail back purified cannabis DNA legally from anywhere in the world as the samples contain zero regulated materials confirmed through 3rd party testing (e.g. no cannabinoids).
Our flagship service, Strain Fingerprint, enables rapid and streamlined individualization of a sample using multiplex qPCR microsatellite assays. This enables Strain Fingerprint to solve the problem of supply chain verification through rapid turnaround that is actionable by various types of producers, regulators, consumers and literally any point along the entire supply chain. It also enables rapid generation of large datasets containing enough samples to perform meaningful statistical analyses on for phenotype (trait) prediction. The latter is the penultimate goal for marker-assisted breeding to improve various aspects of crop yield and specialization.
We've built our company from nothing. I started the lab in a converted bedroom on personal credit in 2017 learning the job of CEO along the way. Naturally, we've had some stumbles scaling, usually aggressively, without access to capital. However, our experience in the trenches has forged a strategy, vision and product-market fit that embraces a new paradigm for how science can be done.